CODING: Words stricken are deletions; words underlined are additions.
                                                  SENATE AMENDMENT
    Bill No. HB 1625, 2nd Eng.
    Amendment No. ___
                            CHAMBER ACTION
              Senate                               House
                                   .
                                   .
  1                                .
                                   .
  2                                .
                                   .
  3                                .
                                   .
  4  ______________________________________________________________
  5
  6
  7
  8
  9
10  ______________________________________________________________
11  Senator Diaz-Balart moved the following amendment:
12
13         Senate Amendment (with title amendment) 
14         On page 99, between lines 11 and 12,
15
16  insert:
17         Section 55.  Florida Commission on Excellence in Health
18  Care.--
19         (1)  LEGISLATIVE FINDINGS AND INTENT.--The Legislature
20  finds that the health care delivery industry is one of the
21  largest and most complex industries in Florida. The
22  Legislature finds that additional focus on strengthening
23  health care delivery systems by eliminating avoidable mistakes
24  in the diagnosis and treatment of Floridians holds tremendous
25  promise to increase the quality of health care services
26  available to Floridians. To achieve this enhanced focus, it is
27  the intent of the Legislature to create the Florida Commission
28  on Excellence in Health Care to facilitate the development of
29  a comprehensive statewide strategy for improving health care
30  delivery systems through meaningful reporting standards, data
31  collection and review, and quality measurement.
                                  1
    1:54 PM   05/04/00                                h1625c-37r9h
                                                  SENATE AMENDMENT
    Bill No. HB 1625, 2nd Eng.
    Amendment No. ___
  1         (2)  DEFINITIONS.--As used in this act, the term:
  2         (a)  "Agency" means the Agency for Health Care
  3  Administration.
  4         (b)  "Commission" means the Florida Commission on
  5  Excellence in Health Care.
  6         (c)  "Department" means the Department of Health.
  7         (d)  "Error," with respect to health care, means an
  8  unintended act, by omission or commission.
  9         (e)  "Health care practitioner" means any person
10  licensed under chapter 457; chapter 458; chapter 459; chapter
11  460; chapter 461; chapter 462; chapter 463; chapter 464;
12  chapter 465; chapter 466; chapter 467; part I, part II, part
13  III, part V, part X, part XIII, or part XIV of chapter 468;
14  chapter 478; chapter 480; part III or part IV of chapter 483;
15  chapter 484; chapter 486; chapter 490; or chapter 491, Florida
16  Statutes.
17         (f)  "Health care provider" means any health care
18  facility or other health care organization licensed or
19  certified to provide approved medical and allied health
20  services in this state.
21         (3)  COMMISSION; DUTIES AND RESPONSIBILITIES.--There is
22  created the Florida Commission on Excellence in Health Care.
23  The commission shall:
24         (a)  Identify existing data sources that evaluate
25  quality of care in Florida and collect, analyze, and evaluate
26  this data.
27         (b)  Establish guidelines for data sharing and
28  coordination.
29         (c)  Identify core sets of quality measures for
30  standardized reporting by appropriate components of the health
31  care continuum.
                                  2
    1:54 PM   05/04/00                                h1625c-37r9h
                                                  SENATE AMENDMENT
    Bill No. HB 1625, 2nd Eng.
    Amendment No. ___
  1         (d)  Recommend a framework for quality measurement and
  2  outcome reporting.
  3         (e)  Develop quality measures that enhance and improve
  4  the ability to evaluate and improve care.
  5         (f)  Make recommendations regarding research and
  6  development needed to advance quality measurement and
  7  reporting.
  8         (g)  Evaluate regulatory issues relating to the
  9  pharmacy profession and recommend changes necessary to
10  optimize patient safety.
11         (h)  Facilitate open discussion of a process to ensure
12  that comparative information on health care quality is valid,
13  reliable, comprehensive, understandable, and widely available
14  in the public domain.
15         (i)  Sponsor public hearings to share information and
16  expertise, identify "best practices," and recommend methods to
17  promote their acceptance.
18         (j)  Evaluate current regulatory programs to determine
19  what changes, if any, need to be made to facilitate patient
20  safety.
21         (k)  Review public and private health care purchasing
22  systems to determine if there are sufficient mandates and
23  incentives to facilitate continuous improvement in patient
24  safety.
25         (l)  Analyze how effective existing regulatory systems
26  are in ensuring continuous competence and knowledge of
27  effective safety practices.
28         (m)  Develop a framework for organizations that
29  license, accredit, or credential health care practitioners and
30  health care providers to more quickly and effectively identify
31  unsafe providers and practitioners and to take action
                                  3
    1:54 PM   05/04/00                                h1625c-37r9h
                                                  SENATE AMENDMENT
    Bill No. HB 1625, 2nd Eng.
    Amendment No. ___
  1  necessary to remove the unsafe provider or practitioner from
  2  practice or operation until such time as the practitioner or
  3  provider has proven safe to practice or operate.
  4         (n)  Recommend procedures for development of a
  5  curriculum on patient safety and methods of incorporating such
  6  curriculum into training, licensure, and certification
  7  requirements.
  8         (o)  Develop a framework for regulatory bodies to
  9  disseminate information on patient safety to health care
10  practitioners, health care providers, and consumers through
11  conferences, journal articles and editorials, newsletters,
12  publications, and Internet websites.
13         (p)  Recommend procedures to incorporate recognized
14  patient safety considerations into practice guidelines and
15  into standards related to the introduction and diffusion of
16  new technologies, therapies, and drugs.
17         (q)  Recommend a framework for development of
18  community-based collaborative initiatives for error reporting
19  and analysis and implementation of patient safety
20  improvements.
21         (r)  Evaluate the role of advertising in promoting or
22  adversely affecting patient safety.
23         (4)  MEMBERSHIP, ORGANIZATION, MEETINGS, PROCEDURES,
24  STAFF.--
25         (a)  The commission shall consist of:
26         1.  The Secretary of Health and the Director of Health
27  Care Administration;
28         2.  One representative each from the following agencies
29  or organizations:  the Board of Medicine, the Board of
30  Osteopathic Medicine, the Board of Pharmacy, the Board of
31  Dentistry, the Board of Nursing, the Florida Dental
                                  4
    1:54 PM   05/04/00                                h1625c-37r9h
                                                  SENATE AMENDMENT
    Bill No. HB 1625, 2nd Eng.
    Amendment No. ___
  1  Association, the Florida Medical Association, the Florida
  2  Osteopathic Medical Association, the Florida Chiropractic
  3  Association, the Florida Chiropractic Society, the Florida
  4  Podiatric Medical Association, the Florida Nurses Association,
  5  the Florida Organization of Nursing Executives, the Florida
  6  Pharmacy Association, the Florida Society of Health System
  7  Pharmacists, Inc., the Florida Hospital Association, the
  8  Association of Community Hospitals and Health Systems of
  9  Florida, Inc., the Florida League of Health Systems, the
10  Florida Health Care Risk Management Advisory Council, the
11  Florida Health Care Association, the Florida Statutory
12  Teaching Hospital Council, Inc., the Florida Statutory Rural
13  Hospital Council, the Florida Association of Homes for the
14  Aging, and the Florida Society for Respiratory Care;
15         3.  Two health lawyers, appointed by the Secretary of
16  Health, one of whom must be a member of the Health Law Section
17  of The Florida Bar who defends physicians and one of whom must
18  be a member of the Academy of Florida Trial Lawyers;
19         4.  Two representatives of the health insurance
20  industry, appointed by the Director of Health Care
21  Administration, one of whom shall represent indemnity plans
22  and one of whom shall represent managed care;
23         5.  Five consumer advocates, consisting of one from the
24  Association for Responsible Medicine, two appointed by the
25  Governor, one appointed by the President of the Senate, and
26  one appointed by the Speaker of the House of Representatives;
27         6.  Two legislators, one appointed by the President of
28  the Senate and one appointed by the Speaker of the House of
29  Representatives; and
30         7.  One representative of a Florida medical school
31  appointed by the Secretary of Health.
                                  5
    1:54 PM   05/04/00                                h1625c-37r9h
                                                  SENATE AMENDMENT
    Bill No. HB 1625, 2nd Eng.
    Amendment No. ___
  1
  2  Commission membership shall reflect the geographic and
  3  demographic diversity of the state.
  4         (b)  The Secretary of Health and the Director of Health
  5  Care Administration shall jointly chair the commission.
  6  Subcommittees shall be formed by the joint chairs, as needed,
  7  to make recommendations to the full commission on the subjects
  8  assigned. However, all votes on work products of the
  9  commission shall be at the full commission level, and all
10  recommendations to the Governor, the President of the Senate,
11  and the Speaker of the House of Representatives must pass by a
12  two-thirds vote of the full commission. Sponsoring agencies
13  and organizations may designate an alternative member who may
14  attend and vote on behalf of the sponsoring agency or
15  organization in the event the appointed member is unable to
16  attend a meeting of the commission or any subcommittee. The
17  commission shall be staffed by employees of the Department of
18  Health and the Agency for Health Care Administration.
19  Sponsoring agencies or organizations must fund the travel and
20  related expenses of their appointed members on the commission.
21  Travel and related expenses for the consumer members of the
22  commission shall be reimbursed by the state pursuant to
23  section 112.061, Florida Statutes. The commission shall hold
24  its first meeting no later than July 15, 2000.
25         (5)  EVIDENTIARY PROHIBITIONS.--
26         (a)  The findings, recommendations, evaluations,
27  opinions, investigations, proceedings, records, reports,
28  minutes, testimony, correspondence, work product, and actions
29  of the commission shall be available to the public, but may
30  not be introduced into evidence at any civil, criminal,
31  special, or administrative proceeding against a health care
                                  6
    1:54 PM   05/04/00                                h1625c-37r9h
                                                  SENATE AMENDMENT
    Bill No. HB 1625, 2nd Eng.
    Amendment No. ___
  1  practitioner or health care provider arising out of the
  2  matters which are the subject of the findings of the
  3  commission. Moreover, no member of the commission shall be
  4  examined in any civil, criminal, special, or administrative
  5  proceeding against a health care practitioner or health care
  6  provider as to any evidence or other matters produced or
  7  presented during the proceedings of this commission or as to
  8  any findings, recommendations, evaluations, opinions,
  9  investigations, proceedings, records, reports, minutes,
10  testimony, correspondence, work product, or other actions of
11  the commission or any members thereof. However, nothing in
12  this section shall be construed to mean that information,
13  documents, or records otherwise available and obtained from
14  original sources are immune from discovery or use in any
15  civil, criminal, special, or administrative proceeding merely
16  because they were presented during proceedings of the
17  commission. Nor shall any person who testifies before the
18  commission or who is a member of the commission be prevented
19  from testifying as to matters within his or her knowledge in a
20  subsequent civil, criminal, special, or administrative
21  proceeding merely because such person testified in front of
22  the commission.
23         (b)  The findings, recommendations, evaluations,
24  opinions, investigations, proceedings, records, reports,
25  minutes, testimony, correspondence, work product, and actions
26  of the commission shall be used as a guide and resource and
27  shall not be construed as establishing or advocating the
28  standard of care for health care practitioners or health care
29  providers unless subsequently enacted into law or adopted in
30  rule. Nor shall any findings, recommendations, evaluations,
31  opinions, investigations, proceedings, records, reports,
                                  7
    1:54 PM   05/04/00                                h1625c-37r9h
                                                  SENATE AMENDMENT
    Bill No. HB 1625, 2nd Eng.
    Amendment No. ___
  1  minutes, testimony, correspondence, work product, or actions
  2  of the commission be admissible as evidence in any way,
  3  directly or indirectly, by introduction of documents or as a
  4  basis of an expert opinion as to the standard of care
  5  applicable to health care practitioners or health care
  6  providers in any civil, criminal, special, or administrative
  7  proceeding unless subsequently enacted into law or adopted in
  8  rule.
  9         (c)  No person who testifies before the commission or
10  who is a member of the commission may specifically identify
11  any patient, health care practitioner, or health care provider
12  by name. Moreover, the findings, recommendations, evaluations,
13  opinions, investigations, proceedings, records, reports,
14  minutes, testimony, correspondence, work product, and actions
15  of the commission may not specifically identify any patient,
16  health care practitioner, or health care provider by name.
17         (6)  REPORT; TERMINATION.--The commission shall provide
18  a report of its findings and recommendations to the Governor,
19  the President of the Senate, and the Speaker of the House of
20  Representatives no later than February 1, 2001. After
21  submission of the report, the commission shall continue to
22  exist for the purpose of assisting the Department of Health,
23  the Agency for Health Care Administration, and the regulatory
24  boards in their drafting of proposed legislation and rules to
25  implement its recommendations and for the purpose of providing
26  information to the health care industry on its
27  recommendations. The commission shall be terminated June 1,
28  2001.
29         Section 56.  The sum of $91,000 in nonrecurring general
30  revenue is hereby appropriated from the General Revenue Fund
31  to the Department of Health to cover costs of the Florida
                                  8
    1:54 PM   05/04/00                                h1625c-37r9h
                                                  SENATE AMENDMENT
    Bill No. HB 1625, 2nd Eng.
    Amendment No. ___
  1  Commission on Excellence in Health Care relating to the travel
  2  and related expenses of staff and consumer members and the
  3  reproduction and dissemination of documents.
  4
  5  (Redesignate subsequent sections.)
  6
  7
  8  ================ T I T L E   A M E N D M E N T ===============
  9  And the title is amended as follows:
10         On page 7, line 13, after the semicolon,
11
12  insert:
13         creating the Florida Commission on Excellence
14         in Health Care; providing legislative findings
15         and intent; providing definitions; providing
16         duties and responsibilities; providing for
17         membership, organization, meetings, procedures,
18         and staff; providing for reimbursement of
19         travel and related expenses of certain members;
20         providing certain evidentiary prohibitions;
21         requiring a report to the Governor, the
22         President of the Senate, and the Speaker of the
23         House of Representatives; providing for
24         termination of the commission; providing an
25         appropriation;
26
27
28
29
30
31
                                  9
    1:54 PM   05/04/00                                h1625c-37r9h